2010
DOI: 10.1016/j.biopsych.2009.09.013
|View full text |Cite
|
Sign up to set email alerts
|

Nucleus Accumbens Deep Brain Stimulation Decreases Ratings of Depression and Anxiety in Treatment-Resistant Depression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

25
471
3
6

Year Published

2010
2010
2016
2016

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 728 publications
(516 citation statements)
references
References 34 publications
25
471
3
6
Order By: Relevance
“…It is important to note, however, that for improvements to be achieved, both these target areas require relatively high stimulation parameters. Furthermore, the stereotactic coordinates of the active electrodes used in both targets are identical in the internal capsule or ventral striatum [78] and the NAcc [115], indicating that the same target is probably involved (the NAcc is located within the ventral striatum).…”
Section: Refractory Depressionmentioning
confidence: 98%
“…It is important to note, however, that for improvements to be achieved, both these target areas require relatively high stimulation parameters. Furthermore, the stereotactic coordinates of the active electrodes used in both targets are identical in the internal capsule or ventral striatum [78] and the NAcc [115], indicating that the same target is probably involved (the NAcc is located within the ventral striatum).…”
Section: Refractory Depressionmentioning
confidence: 98%
“…DBS aims to modulate dysfunctional neuronal networks involved in depression (Krishnan and Nestler, 2010). Three major brain regions have been selected in a hypothesisdriven way for major depression: nucleus accumbens (NAcc) (Bewernick et al, 2010;Schlaepfer and Lieb, 2005), subgenual cingulate cortex (Cg 25 ) Mayberg et al, 2005) and the anterior limb of the capsula interna (ALIC) (Malone et al, 2009). Although the precise mechanism of action is not known yet, significant antidepressant effects have been shown in a 1-year follow-up period in 50-60% of the about 45 treated patients (Bewernick et al, 2010;Lozano et al, 2008;Malone et al, 2009).…”
Section: Introductionmentioning
confidence: 99%
“…The NAc acts as a central regulator of emotional behaviors, and its function is tightly modulated by a number of molecular mechanisms, including histone deactylases, IkK, and DFosB, among others (Christoffel et al, 2011a;Covington et al, 2009;Vialou et al, 2010). Importantly, the NAc is a relevant target for therapeutic exploration in major depressive disorder, as deep brain stimulation of the NAc reduces anxiety and depression in previously treatment-resistant major depressive disorder patients (Bewernick et al, 2010). These findings highlight the critical role of NAc in emotional behaviors and suggest that novel modulators of neuronal function in NAc may improve therapeutic outcomes for psychiatric patients.…”
Section: Introductionmentioning
confidence: 99%